Samsung Biologics has launched an all-cash public tender offer to acquire 100% of the fully diluted share capital of ...

Natoli Engineering Company Inc. has acquired Scheu & Kniss, a company with 100+ of experience providing tablet press ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, appointed Torsten Woehr as Chief Executive Officer, effective ...

OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...

Halozyme’s proprietary Enhanze drug delivery tech may have potential to strengthen formulations currently in development. Contract Pharma is the premier media outlet linking contract service providers ...

Bora Pharmaceuticals has completed its acquisition of MacroGenics, Inc.’s GMP manufacturing operations, including its ...

AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an ...

EpilepsyGTx, a biotechnology company, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and ...

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...